Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Kalos_Therapeutics> ?p ?o }
Showing triples 1 to 36 of
36
with 100 triples per page.
- Kalos_Therapeutics abstract "Kalos Therapeutics is a biomedical company with the exclusive patent to develop the ANP (atrial natriuretic peptide) family of peptides as a new mechanism for the treatment of cancer.Kalos has been covered by ABC News on Good Morning America, and profiled in Business Week and Time Magazine. The company aggressively targets diseases caused by an abnormally high growth rate of cells (hyper proliferation), and is pioneering an approach to cancer treatment by developing peptides made primarily in the heart, as a cytostatic therapeutic for treating aggressive cancers by engaging known pathway receptors more efficiently without the side effects associated with chemotherapeutic or small molecule compounds.KT-220, the current lead drug candidate, demonstrates remarkably broad anti-cancer activity. KT-220 has inhibited the growth of pancreatic, lung, prostate, breast, ovarian, colon, and melanoma cells in culture and of pancreatic, breast, and lung cancer tumors in models of human cancer.".
- Kalos_Therapeutics thumbnail Kalos_logo.jpg?width=300.
- Kalos_Therapeutics wikiPageExternalLink playerIndex?id=9215291.
- Kalos_Therapeutics wikiPageExternalLink snapshot.asp?privcapid=142012371Bloomberg.
- Kalos_Therapeutics wikiPageExternalLink cancer-drug-firm-says-hormones-produced-in-the-heart-have-serious-tumor-fighting-potential.
- Kalos_Therapeutics wikiPageExternalLink detail.php?c=3826651k$SnwUICRlARTY.
- Kalos_Therapeutics wikiPageExternalLink kalos-therapeutics-data-confirming-anti-cancer-naturally-occurring-heart-hormones-presented-3822.html.
- Kalos_Therapeutics wikiPageID "37920021".
- Kalos_Therapeutics wikiPageLength "3203".
- Kalos_Therapeutics wikiPageOutDegree "11".
- Kalos_Therapeutics wikiPageRevisionID "667425638".
- Kalos_Therapeutics wikiPageWikiLink Atrial_natriuretic_peptide.
- Kalos_Therapeutics wikiPageWikiLink Bloomberg_Businessweek.
- Kalos_Therapeutics wikiPageWikiLink Category:Biomedical_engineering.
- Kalos_Therapeutics wikiPageWikiLink Covidien.
- Kalos_Therapeutics wikiPageWikiLink Daniel_Von_Hoff.
- Kalos_Therapeutics wikiPageWikiLink Gentech_Pharmaceutical.
- Kalos_Therapeutics wikiPageWikiLink Good_Morning_America.
- Kalos_Therapeutics wikiPageWikiLink Medical_research.
- Kalos_Therapeutics wikiPageWikiLink Time_(magazine).
- Kalos_Therapeutics wikiPageWikiLink Translational_Genomics_Research_Institute.
- Kalos_Therapeutics wikiPageWikiLink File:Kalos_logo.jpg.
- Kalos_Therapeutics wikiPageUsesTemplate Template:Advert.
- Kalos_Therapeutics wikiPageUsesTemplate Template:Orphan.
- Kalos_Therapeutics wikiPageUsesTemplate Template:Reflist.
- Kalos_Therapeutics subject Category:Biomedical_engineering.
- Kalos_Therapeutics hypernym Company.
- Kalos_Therapeutics type Company.
- Kalos_Therapeutics comment "Kalos Therapeutics is a biomedical company with the exclusive patent to develop the ANP (atrial natriuretic peptide) family of peptides as a new mechanism for the treatment of cancer.Kalos has been covered by ABC News on Good Morning America, and profiled in Business Week and Time Magazine.".
- Kalos_Therapeutics label "Kalos Therapeutics".
- Kalos_Therapeutics sameAs Q6354289.
- Kalos_Therapeutics sameAs m.0p76wyt.
- Kalos_Therapeutics sameAs Q6354289.
- Kalos_Therapeutics wasDerivedFrom Kalos_Therapeutics?oldid=667425638.
- Kalos_Therapeutics depiction Kalos_logo.jpg.
- Kalos_Therapeutics isPrimaryTopicOf Kalos_Therapeutics.